Distribution of short and lifetime risks for cardiovascular disease in Italians

European Journal of Preventive Cardiology

Volumn 19, Issue 4, 2012, Pages 723-730

  Di Castelnuovo, Augusto ^a   Costanzo, Simona ^a   Persichillo, Mariarosaria ^a   Olivieri, Marco ^a   De Curtis, Amalia ^a   Zito, Francesco ^a   Donati, Maria Benedetta ^a   De Gaetano, Giovanni ^a   Iacoviello, Licia ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

cardiovascular disease; health status; primary prevention; public health; Risk prediction

Indexed keywords

ADULT; ALGORITHM; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HUMAN; LIFESPAN; MALE; PRIMARY PREVENTION; PRIORITY JOURNAL; AGE; AGE DISTRIBUTION; CROSS-SECTIONAL STUDY; DECISION SUPPORT SYSTEM; HEALTH STATUS; ITALY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SEX RATIO; TIME;

ADULT; AGE DISTRIBUTION; AGE FACTORS; ALGORITHMS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DECISION SUPPORT TECHNIQUES; FEMALE; HEALTH STATUS; HUMANS; ITALY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; TIME FACTORS;

EID: 84867889691     PISSN: 20474873     EISSN: None     Source Type: Journal    
DOI: 10.1177/1741826711410820     Document Type: Article

References (26)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002 ; 106: 3143-3421
2. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases: American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002 ; 106: 388-391
3. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, et al. National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004 ; 110: 227-239
4. Aspirin for the prevention of cardiovascular disease: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009 ; 150: 396-404
5. D'Agostino Sr RB, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001 ; 286: 180-187
6. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. SCORE project group. Estimation of ten year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003 ; 24: 987-1003
7. Ferrario M, Chiodini P, Chambless LE, Cesana G, Vanuzzo D, Panico S, et al. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. Int J Epidemiol. 2005 ; 34: 413-421
8. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ. 2008 ; 336: 1475-1482
9. Berry JD, Lloyd-Jones DM, Garside DB, Greenland P. Framingham risk score and prediction of coronary heart disease death in young adults. Am Heart J. 2007 ; 154: 80-86
10. Ford ES, Giles WH, Mokdad AH. The distribution of 10-Year risk for coronary heart disease among U.S. adults: findings from the National Health and Nutrition Examination Survey III. J Am Coll Cardiol. 2004 ; 43: 1791-1796
11. Sibley C, Blumenthal RS, Merz CN, Mosca L. Limitations of current cardiovascular disease risk assessment strategies in women. J Womens Health (Larchmt). 2006 ; 15: 54-56
12. Mosca L, Banka CL, Benjamin EJ, Berra K, Bushnell C, Dolor RJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation. 2007 ; 115: 1481-1501
13. Lloyd-Jones DM, Leip EP, Larson MG, D'Agostino RB, Beiser A, Wilson PW, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006 ; 113: 791-798
14. Persell SD, Zei C, Cameron KA, Zielinski M, Lloyd-Jones DM. Potential use of 10-year and lifetime coronary risk information for preventive cardiology prescribing decisions: A primary care physician survey. Arch Intern Med. 2010 ; 170: 470-477
15. Marma AK, Berry JD, Ning H, Persell SD, Lloyd-Jones DM. Distribution of 10-year and lifetime predicted risks for cardiovascular disease in US adults: findings from the National Health and Nutrition Examination Survey 2003-2006. Circ Cardiovasc Qual Outcomes. 2010 ; 3: 8-14
16. Iacoviello L, Bonanni A, Costanzo S, De Curtis A, Di Castelnuovo A, Olivieri M, et al. on behalf of the Moli-sani Project Investigators. The Moli-Sani Project, a randomized, prospective cohort study in the Molise region in Italy; design, rationale and objectives. Ital J Public Health. 2007 ; 4: 110-118
17. Centritto F, Iacoviello L, di Giuseppe R, De Curtis A, Costanzo S, Zito F, et al. on behalf of Moli-sani Investigators. Dietary patterns, cardiovascular risk factors and C-reactive protein in a healthy Italian population. Nutr Metab Cardiovasc Dis. 2009 ; 19: 697-706
18. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001 ; 285: 2486-2497
19. Lloyd-Jones DM, Dyer AR, Wang R, Daviglus ML, Greenland P. Risk factor burden in middle age and lifetime risks for cardiovascular and non-cardiovascular death. Am J Cardiol. 2007 ; 99: 535-540
20. Berry JD, Liu K, Folsom AR, Lewis CE, Carr JJ, Polak JF, et al. Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the CARDIA and MESA studies. Circulation. 2009 ; 119: 382-389
21. Elward KS, Simpson RJ, Mendys P. Improving cardiovascular risk reduction for primary prevention - utility of lifetime risk assessment. Postgrad Med. 2010 ; 122: 192-199
22. Berger JS, Jordan CO, Lloyd-Jones D, Blumenthal RS. Screening for cardiovascular risk in asymptomatic patients. J Am Coll Cardiol. 2010 ; 55: 1169-1177
23. Persell SD, Lloyd-Jones DM, Baker DW. Implications of changing National Cholesterol Education Program goals for the treatment and control of hypercholesterolemia. J Gen Intern Med. 2006 ; 21: 171-176
24. Palmieri L, Donfrancesco C, Giampaoli S, Trojani M, Panico S, Vanuzzo D, et al. Favorable cardiovascular risk profile and 10-year coronary heart disease incidence in women and men: results from the Progetto CUORE. Eur J Cardiovasc Prev Rehabil. 2006 ; 13: 562-570
25. Chambless LE, Heiss G, Shahar E, Earp MJ, Toole J. Prediction of ischemic stroke risk in the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2004 ; 160: 259-269
26. Donfrancesco C, Palmieri L, Cooney MT, Vanuzzo D, Panico S, Cesana G, Ferrario M, Pilotto L, Graham IM, Giampaoli S. Italian cardiovascular mortality charts of the CUORE project: are they comparable with the SCORE charts?. Eur J Cardiovasc Prev Rehabil. 2010 ; 17 (4). 403-409